baber/WOPTO huggingface dataset:
Patent DE-69230139-T2 (DE)
Inventor: KING REGINALD ALFRED
IPC: G06N3/04
Filed: 1992-02-18
Granted: 2000-07-20
Abstract: A signal processing system for time varying band-limited signals such as speech comprises signal coding means for affording a time encoded signal symbol stream, a matrix generator for generating a fixed size, typically "A" matrix from the symbol stream, and an artificial neural network to which the matrix elements are applied for network training and subsequently for affording an output indicative of the nature of an input signal.
Patent DE-69230182-T2 (DE)
Inventor: DORIGATTI FRANCO
IPC: D04H1/42
Filed: 1992-12-18
Granted: 2000-08-31
Abstract: Biomaterials are disclosed comprised of biodegradable, biocompatible, and bioabsorbable composite membranes for use in surgery for the guided regeneration of tissues. The composite membranes are comprised of threads embedded in a matrix, wherein both the matrix and the threads can be comprised of esters of hyaluronic acid, used singly or in combination, or esters of hyaluronic acid in combination with esters of alginic acid or other polymers.
Patent DE-69306408-T2 (DE)
Inventor: HUGHES CLIFFORD
IPC: H01Q1/12
Filed: 1993-09-24
Granted: 1997-03-27
Abstract: PCT No. PCT/FR93/00937 Sec. 371 Date Mar. 7, 1996 Sec. 102(e) Date Mar. 7, 1996 PCT Filed Sep. 24, 1993 PCT Pub. No. WO94/08360 PCT Pub. Date Apr. 14, 1994The disclosed mount comprises a first dihedral (ABC, BCD) of which one of the planes (ABC) is borne on a support base; means (6) for adjusting the angle ( alpha ) of said first dihedral; a second dihedral (BCD, BDE) of which one of the planes (BCD) is common to the first dihedral and the other plane (BDE) carries means (8) for supporting the antenna, the axis (BC) of the first dihedral and the axis (BD) of the second dihedral being neither parallel nor merged; and means (7) for adjusting the angle ( beta ) of said second dihedral.
Patent DE-69310411-T2 (DE)
Inventor: TREVISANI DAVIDE
IPC: E21D11/10
Filed: 1993-02-11
Granted: 1997-10-09
Abstract: A tunnel excavation apparatus (20) comprises a frame (21) mounted on crawler tacks (29,46) and provided with pistons comprising stabilizer feet, a power unit (24), a working unit (26), and auxiliary movement and positioning services. The working unit (26) is arranged on an arm mounted on one end of telescopic uprights (25), which are hinged at their other end to the frame (21) about an axis substantially parallel to the longitudinal direction of the machine, and consists of a rectilinear rigid structure, at the perimeter of which excavation tools (35) are arranged on a chain, to circulate along the side and front of the structure (41). The tools are hinged to a caisson (38) open on the side opposite the hinged side and provided with means (40) for conveying concrete into its interior. <IMAGE>
Patent DE-69316380-T2 (DE)
Inventor: DICKINSON ROGER PETER
IPC: A61K31/19
Filed: 1993-09-14
Granted: 1998-04-30
Abstract: PCT No. PCT/EP93/02488 Sec. 371 Date Mar. 15, 1995 Sec. 102(e) Date Mar. 15, 1995 PCT Filed Sep. 14, 1993 PCT Pub. No. WO94/06761 PCT Pub. Date Mar. 31, 1994Compounds of formula (I) wherein R1, R2, R3 and R4 are each H or C1-C4 alkyl; R5 is (CH2)mNHSO2R6 or (CH)mNHCOR6; R6 is C1-C6 alkyl, C3-C6 cycloalkyl optionally substituted by aryl, aryl or heteroaryl; R7 is H, C1-C4 alkyl, C1-C4 alkoxy, halo, CF3, OCF3, CN, CONH2, or S(O)n(C1-C4 alkyl); X is CH2, CHCH3, CH(OH), C(OH)CH3, C=CH2, CO or O; m is 0 or 1 and n is 0, 1 or 2, and their pharmaceutically acceptable salts and biolabile esters, are antagonists of thromboxane A2 of utility, particulary in combination with a thromboxane synthetase inhibitor, in the treatment of atherosclerosis and unstable angina and for prevention of reocclusion after percutaneous transluminal angioplasty.
Patent DE-69320550-T2 (DE)
Inventor: MAEKIMAA TAPANI
IPC: B23K9/10
Filed: 1993-06-07
Granted: 1999-03-18
Abstract: The invention concerns an apparatus and method for remote-controlling a power supply unit (3) and/or an auxiliary unit (55, 57) of a welding machine by means of radio-frequency signals. The apparatus comprises a welding torch (1), a welding cable (2) connected to the welding torch (1), a welding power supply unit (3) connected to the other end of said welding cable (2), a radio-frequency transmitter (9) situated close to said welding torch (1) and/or said auxiliary unit (55), and a radio-frequency receiver (4) connected to said welding power supply unit (3) and/or said auxiliary unit (55, 57). According to the invention, both the radio-frequency transmitter (9) and receiver (8) are coupled capacitively or inductively onto the welding cable (2) for the purpose of transmitting a radio-frequency remote-control signal over the welding cable (2). <IMAGE>
Patent DE-69324159-T2 (DE)
Inventor: BLACKBURN PETER
IPC: A01N63/50
Filed: 1993-12-08
Granted: 2009-09-10
Abstract: The invention concerns compositions containing a lanthionine containing bacteriocin such as nisin which are stabilized by the presence of a thioether stabilizing agent against degradation.
Patent DE-69400357-T2 (DE)
Inventor: KORHONEN VILLE
IPC: D21H23/56
Filed: 1994-01-21
Granted: 1997-01-16
Abstract: The invention concerns a size press, comprising a first roll (12), which is mounted rigidly on the frame (11) of the size press, as well as a second roll (16), which forms a size-press nip (N) with the first roll and which is mounted, at a level higher than the level of said first roll (12), on a loading arm (19) that is supported pivotally on a transverse shaft (20) on the frame (11) of the size press. The loading arm (19) can be pivoted by means of loading cylinders (22) so as to produce the desired pressure level in the nip (N) and to open said nip for threading of the web (W) and for replacement of rolls. The paper web (W) is passed into the nip (N) as guided by a guide roll (23) and out of the nip (N) over a spreader roll (25) or an air-turning device. The rolls (12) that form the size-press nip (N) have been arranged in such a way in relation to one another that the nip plane passing through the rolls forms an angle of 35...120 DEG , advantageously 50...60 DEG , preferably 55 DEG , in relation to the horizontal plane. The web (W) has been arranged to be passed into the nip (N) at an angle of substantially 90 DEG  in relation to the nip plane and to be passed out of the nip (N) at an angle of 90 DEG  +/- 7 DEG  in relation to the nip plane. <IMAGE>
Patent DE-69421461-T2 (DE)
Inventor: DEVEAU JACQUES
IPC: A23L27/40
Filed: 1994-07-19
Granted: 2000-03-16
Abstract: The invention relates to the use, for the salting and preservation of meat products, of a composition comprising sodium chloride and at least two salts chosen from magnesium chloride, calcium chloride and potassium chloride, sodium chloride representing at least 50% by weight of the composition, whereas the magnesium chloride represents at most 30% by weight of this composition and the calcium chloride represents at most 10% by weight thereof, the balance for 100% consisting essentially of potassium chloride.
Patent DE-69425199-T2 (DE)
Inventor: IMANAKA YOSHIYUKI
IPC: H05K1/02
Filed: 1994-08-25
Granted: 2001-03-15
Abstract: An ink jet recording head detachably mountable to a main assembly of a recording apparatus includes ejection energy generating elements for generating energy for ejecting ink; wiring for supplying electric signals to the ejection energy generating elements; electric contacts, connected with the wiring, for receiving the electric signals; and an electric discharge path, provided at least a part of a periphery of the electric contacts, for releasing static electricity. <IMAGE>
Patent DE-69426115-T2 (DE)
Inventor: DALTON ROBERT E
IPC: B29C43/44
Filed: 1994-06-15
Granted: 2001-06-21
Abstract: A continuously operating press for pressing a web of material together has a press zone at an input side a calibration zone at an output side. This press may be used in the formation of particle board by applying heat and pressure to press the web of material together to form the particle board. Preferably, the press has a lower press platen and an upper press platen that are pressed together to form the particle board. Both the lower press platen and the upper press platen preferably have a PTFE composite pressure pad. This composite pressure pad may have a layer of virgin PTFE and a layer of filled PTFE. The layer of filled PTFE is preferably partially compressed at a pressure of about 14.7 psi. After which, the layer of filled PTFE is preferably compression molded with the layer of virgin PTFE to form a composite. This composite may also be sintered and coined.
Patent DE-69431089-T2 (DE)
Inventor: OSHLACK BENJAMIN
IPC: A61K31/522
Filed: 1994-06-14
Granted: 2003-03-27
Abstract: The invention concerns controlled release oxycodone dosage forms comprising a multiparticulate system substrate comprising an amount of an oxycodone salt, the substrate being coated with an aqueous dispersion of at least one hydrophobic polymer, whereby the coating provides controlled release, the substrate including an additional dose of an oxycodone salt included in either the controlled release coating or in an additional overcoating coated on the outer surface of the controlled release coating, whereby the dosage forms, comprising the cured, coated substrate, comprise an effective amount of an oxycodone salt and provide a therapeutic effect for at least 12 hours when administered to a patient.
Patent DE-69431470-T2 (DE)
Inventor: YOSHINO HIROSHI
IPC: C07D513/04
Filed: 1994-07-26
Granted: 2003-08-14
Abstract: Novel antitumor sulfonamide and sulfonic ester derivatives each having a tricyclic hetero ring, represented by general formula (I), and a process for producing the same, wherein G represents a 5- or 6-membered aromatic ring; L represents O or NR<1>, wherein R<1> represents hydrogen or lower alkyl; and M represents a tricyclic structure selected from the members (a), (b), (c), (d), (e), (f), wherein rings A and B represent each a 5- or 6-membered unsaturated ring; X represents NR<2> (wherein R<2> represents hydrogen or lower alkyl) or NHCO; Y represents O, S(O)n, CR<3>R<4>, CO, NR<5>, CHR<6>CHR<7>, CR<8>=CR<9>, NR<1><0>CO, N=CR<1><1>, OCHR<1><2>, S(O)nCHR<1><3> or NR<1><4>CHR<1><5>; and Z represents N or CR<1><6>, wherein n represents 0, 1 or 2; R<3>-R<1><3>, R<1><5> and R<1><6> represent each hydrogen or lower alkyl; and R<1><4> represents hydrogen, lower alkyl or lower acyl. <CHEM>
Patent DE-69433499-T2 (DE)
Inventor: KOFOD LENE VENKE
IPC: A23L29/00
Filed: 1994-03-02
Granted: 2004-12-02
Abstract: An enzyme exhibiting xylanase activity, which enzyme is immunologically reactive with an antibody raised against a purified xylanase derived from Aspergillus aculeatus, CBS 101.43. The enzyme may be used for degrading plant cell wall components e.g. in the preparation of feed, in baking, in the paper and pulp industry and in connection with separation of wheat into starch and gluten.
Patent DE-69509626-T2 (DE)
Inventor: NUMATA YOSHITO
IPC: C12P21/08
Filed: 1995-12-07
Granted: 2000-01-13
Abstract: The present invention relates to a sandwich immunoassay for rapidly and readily measuring N-peptide using two kinds of monoclonal antibodies recognizing different portions of the N-peptide. The method for measuring N-peptide or a precursor thereof includes the steps of: incubating a mixture containing a sample and a first monoclonal antibody recognizing a portion of N-peptide; adding a labelled second monoclonal antibody recognizing a portion of N-peptide to the mixture, followed by further incubation; and detecting the resulting antigen-antibody complex in the mixture. Alternatively, the method includes the steps of: incubating a mixture containing a sample, a first monoclonal antibody recognizing a portion of N-peptide, and a labelled second monoclonal antibody recognizing another portion of N-peptide; and detecting the resulting antigen-antibody complex.
Patent DE-69510606-T2 (DE)
Inventor: VENTURINI GIANCARLO
IPC: B60W30/18
Filed: 1995-05-12
Granted: 2000-02-24
Abstract: The invention refers to a device for transmitting acceleration, braking and like manual controls, particularly from the vehicle steering wheel, comprising a circular bearing element (4, 5; 12) upon which a plurality of lever elements (1; 11; 21) is provided, said lever elements being swingable in order to swing on said bearing element (4, 5; 12) all together between a rest position and control transmission positions by the manual action of the driver, and to elastically come back to the rest position once finished the manual action; at least one of said lever element (1, 11; 21) acting, when is in one of the operative positions, on a potentiometer element. <IMAGE>
Patent DE-69510668-T2 (DE)
Inventor: FOUNDS HENRY
IPC: G01N33/531
Filed: 1995-04-28
Granted: 1999-10-28
Abstract: The present invention relates to methods for the diagnosis and monitoring of diseases and disorders associate with advanced glycosylation endproducts (AGE) formation, such as diabetes and the ageing process. In particular, the invention is directed to detecting AGE-modified hemoglobin (Hb-AGE) for the foregoing purposes, and in improved assay therefore. The method involves diluting the sample in a dilution buffer, which dilution buffer comprises an anionic protein denaturing detergent at a concentration sufficient to denature hemoglobin-AGE without interfering in binding of reagents with hemoglobin-AGE the dilution buffer may also include a non-ionic surfactant at a concentration sufficient to facilitate detection of hemoglobin-AGE; and a denaturing agent at a concentration sufficient to denature hemoglobin-AGE and increase assay sensitivity, without denaturing binding of reagents to hemoglobin-AGE. After diluting the sample in the dilution buffer, the sample is contacted with means for detecting the presence of hemoglobin-AGE in the sample, and the presence of hemoglobin-AGE in the sample is detected with the detection means. Dilution buffers and kits for practicing the invention are also provided. In specific examples, the level of AGE in hemoglobin in samples from human and rat normal subjects and diabetic subjects is detected. The results obtained from human samples show a high degree of correlation between the level of hemoglobin-AGE in a sample and the level of hemoglobin-A1c in a sample. Most importantly, the invention is used to detect the "aminoguanidine effect," which is the decrease in the level of hemoglobin-AGE in a sample from a subject undergoing therapy with the AGE-inhibitor aminoguanidine.
Patent DE-69511072-T2 (DE)
Inventor: NODA ISAO
IPC: D04H1/42
Filed: 1995-02-10
Granted: 2000-03-09
Abstract: The present invention comprises processes for preparing biodegradable fibrils from one or more biodegradable homopolymeric or copolymeric resins, said process comprising: a) forming a liquid resin mixture by melting or solvating the resin or resins; and b) introducing the liquid resin mixture to a flow of a gaseous substance. The present invention further comprises biodegradable fibrils made according to the processes of the present invention. The invention further comprises nonwoven fabrics comprising biodegradable fibrils. The invention further comprises disposable absorbent articles comprising a water-permeable topsheet, an absorbent core, and a water-impermeable backsheet, wherein the topsheet comprises a nonwoven substrate comprising biodegradable fibrils. The invention further comprises disposable articles comprising biodegradable fibrils.
Patent DE-69523824-T2 (DE)
Inventor: MCGILL JOHN MCNEILL
IPC: C07D451/04
Filed: 1995-06-23
Granted: 2002-06-13
Abstract: A stereoselective process for forming compounds related to 4-endotropanamine through the reactive amination of a corresponding ketone with a triacyloxy borohydride.
Patent DE-69527425-T2 (DE)
Inventor: FEULING JAMES J
IPC: F02F1/42
Filed: 1995-05-15
Granted: 2003-01-16
Abstract: An intake and exhaust system for use with international combustion engines that uses two intake valves and one exhaust valve for each cylinder. The three valves are preferably round and spaced around the cylinder centreline in the cylinder head. The two intake valves may be spaced closer to the exhaust valve than to each other. The two intake valves may, alternatively, be spaced closer to each other than to the exhaust valve and two spark plugs may be provided, each lying between an intake valve and the exhaust valve. For best results, the two intake valves have substantially equal diameters, with the diameter of the exhaust valve having a ratio to the diameter of an intake valve of from about 1:1 to 1:1:2. The head has three substantially hemispheric depressions, each housing one of said valves. Squish areas are preferably provided between each pair of adjacent valves around the combustion chamber periphery. This invention provides a fast and uniform lean-burn, permits use of a high compression ratio and lower octane, unleaded gasoline and provides improved thermal efficiency. <IMAGE>
Patent DE-69531619-T2 (DE)
Inventor: REYLAND TREVOR
IPC: E04G5/04
Filed: 1995-06-23
Granted: 2004-06-17
Abstract: A scaffolding assembly comprises, in this case, four uprights spaced along the wall structure with each upright being about the same distance from the wall structure, each upright has a lower end on the ground and an upper end adjacent the roof. Building engagement means in the form of roof mounting brackets extend from the building to each upright to hold the upper ends of the uprights in fixed space relation to the building, adjacent uprights have respective carriages and hand winches respectively for independently raising or lowering the carriage incrementally in turn in order to raise and lower platforms. To this end the platforms are pivotally supported and extend toward the wall structure so that service personnel can raise and lower the platforms to work on the wall structure.
Patent DE-69604597-T2 (DE)
Inventor: POPLAWSKI LUCJAN
IPC: B41K1/40
Filed: 1996-02-21
Granted: 2000-05-04
Abstract: PCT No. PCT/NL96/00084 Sec. 371 Date Jun. 17, 1998 Sec. 102(e) Date Jun. 17, 1998 PCT Filed Feb. 21, 1996 PCT Pub. No. WO97/22478 PCT Pub. Date Jun. 26, 1997A mounting for a manual stamp has an outer casing, a stamp-carrying body that is slidably mounted in the outer casing against a spring loading force, and a protective cover. One of the stamp-carrying body and the cover has a resilient tongue, and the other has a locking member engageable with the tongue. When the cover is placed on the stamp-carrying body, the latter can be pushed into a retracted position within the outer casing and be locked in that position by latching of the tongue with the locking member.
Patent DE-69617928-T2 (DE)
Inventor: MIS JOSEPH DANIEL
IPC: H01L21/288
Filed: 1996-03-18
Granted: 2002-07-18
Abstract: A method for forming solder bumps (42) on a microelectronic device having a substrate (22) and a contact pad (24) on said substrate (22), wherein said contact pad (24) has an exposed surface portion. The method comprises forming a titanium barrier layer (28) on said contact pad (24), wherein said barrier layer (28) covers said exposed surface portion of said contact pad (24) and extends over said substrate; forming an under bump metallurgy layer on said barrier layer (28) opposite said substrate (22); forming a solder bump (42) on said under bump metallurgy layer opposite said exposed surface portion of said contact pad (24) and said barrier layer (28) thereby defining exposed and unexposed surface portions of said under bump metallurgy layer; selectively removing said exposed portion of said under bump metallurgy layer thereby defining an exposed portion of said barrier layer (28) and selectively removing said exposed portion of said barrier layer (28). The step of forming an under bump metallurgy layer comprises the steps of forming a chromium layer (30) on said titanium barrier layer (28) and forming a copper layer (34) on said chromium layer (30) opposite said barrier layer (28). <IMAGE>
Patent DE-69622894-T2 (DE)
Inventor: TALLEY JOHN JEFFREY
IPC: A61P29/00
Filed: 1996-05-31
Granted: 2003-04-30
Abstract: This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds, compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase, such as inflammation.
Patent DE-69628834-T2 (DE)
Inventor: SMITH GALE EUGENE
IPC: A61K39/12
Filed: 1996-04-26
Granted: 2004-05-06
Abstract: Improved mammalian virus vaccines are combinations that contain an immunogenic amount of inactivated virus, such as influenza virus, Herpes varicella virus, measles virus, Epstein Barr virus, respiratory syncytial virus, parainfluenza 3, Herpes simplex type 1 virus, and Herpes simplex type 2 virus, and an immunogenic amount of a purified recombinant envelope protein from the virus, or a fragment or precursor of the protein. Alternatively, they contain either inactivated virus and/or envelope protein antigens and an adjuvant such as granulocyte-microphage colony stimulating factor. One embodiment of an influenza vaccine is prepared by combining inactivated virus, preferably three strains of the virus, and hemagglutinin, preferably a combination of respective hemagglutinins for each of the three strains present. In another embodiment, an influenza vaccine is prepared by combining inactivated virus, again preferably three strains of the virus, and neuraminidase, preferably a combination of respective neuraminidase for each of the three strains present. In a third embodiment, the vaccine contains inactivated virus and both hemagglutinin and neuraminidase, preferably using three strains of each. Granulocyte-macrophage colony stimulating factor is, optionally, added to these embodiments.
Patent DE-69630446-T2 (DE)
Inventor: HARVEY BLUE
IPC: C08K5/1535
Filed: 1996-05-15
Granted: 2004-07-29
Abstract: PCT No. PCT/GB96/01156 Sec. 371 Date Feb. 25, 1998 Sec. 102(e) Date Feb. 25, 1998 PCT Filed May 15, 1996 PCT Pub. No. WO96/36663 PCT Pub. Date Nov. 21, 1996The present invention relates to a composition based on polymer and/or co-polymers of vinyl chloride including organotin salts and/or one or more divalent metal salts of a carboxylic acid or phenol, and one or more metal salts of the organic compounds of general formula A: in which R1 represents a linear or branched alkylene or alkenylene radical having up to 20 carbon atoms, an aralkylene radical having from 7 to 20 carbon atoms or an arylene or cycloalkylene radical having from 6 to 20 carbon atoms, the cycloalkylene radicals optionally containing carbon-carbon double bonds; these radicals optionally being unsubstituted or substituted for example by one or more or halogen atoms or hydroxyl groups or, for aryl or cycloalkylene radicals, by one or more methyl, ethyl or methoxy radicals, the above-mentioned radicals optionally modified by the presence in an aliphatic chain of one or more -O-, -CO- or CO2 -chain members or N; R2 represents O,S,NR5 or NNHR5 wherein R5 is defined as R1, H or C(S)NHR6 wherein R6 is defined as R1 or H; R3 and R4 are defined as R1 or H and can be the same or different; A is either, O, S or NR7, with R7 defined as R1 and H, with the exception that when A =O, R2=+544 =O.
Patent DE-69632465-T2 (DE)
Inventor: JOLIFFE K
IPC: C07K16/28
Filed: 1996-06-06
Granted: 2005-06-23
Abstract: The present invention provides CDR-grafted antibodies against human tissue factor that retain the high binding affinity of rodent monoclonal antibodies against tissue factor but have reduced immunogenicity. The present humanized antibodies are potent anticoagulants and are thus useful in the treatment and prophylaxis of human thrombotic disease. The invention also provides methods of making the CDR-grafted antibodies and pharmaceutical compositions for the attenuation or prevention of coagulation.